NCT05465954 2026-01-12Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent GlioblastomaMayo ClinicPhase 2 Recruiting54 enrolled
NCT04588038 2025-02-14NT-I7 for the Treatment of Recurrent Squamous Cell Carcinoma of Head and Neck Undergoing SurgeryUniversity of California, San FranciscoPhase 1 Terminated4 enrolled